Treatment of disseminated granuloma annulare with low-dose fumaric acid

Acta Dermato-Venereologica

Volumn 89, Issue 3, 2009, Pages 295-298

  Weber, H Oliver ^a   Borelli, Claudia ^b   Röcken, Martin ^a   Schaller, Martin ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Fumaric acid esters; Granuloma annulare; Low dose

Indexed keywords

FUMADERM; FUMADERM INITIAL; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADULT; ARTICLE; CLINICAL ARTICLE; DIARRHEA; DISSEMINATED GRANULOMA ANNULARE; DRUG DOSE INCREASE; DRUG WITHDRAWAL; EOSINOPHILIA; FEMALE; GRANULOMA ANNULARE; HUMAN; LEUKOPENIA; LOW DRUG DOSE; MALE; NAUSEA; PRIORITY JOURNAL; TREATMENT RESPONSE;

ADMINISTRATION, ORAL; DERMATOLOGIC AGENTS; FEMALE; FUMARATES; GRANULOMA ANNULARE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 66749127919     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0647     Document Type: Article

References (17)

1. Smith MD, Downie JB, DiCostanzo D. Granuloma annulare. Int J Dermatol 1997; 36: 326-333.
2. Dahl MV. Granuloma annulare: long-term follow-up. Arch Dermatol 2007; 143: 946-947.
3. Nebesio CL, Lewis C, Chuang TY. Lack of an association between granuloma annulare and type 2 diabetes mellitus. Br J Dermatol 2002; 146: 122-124.
4. Fayyazi A, Schweyer S, Eichmeyer B, Herms J, Hemmerlein B, Radzun HJ, et al. Expression of IFNgamma, coexpression of TNF alpha and matrix metalloproteinases and apoptosis of T lymphocytes and macrophages in granuloma annulare. Arch Dermatol Res 2000; 292: 384-390.
5. Salomon N, Walchner M, Messer G, Plewig G, Röcken M. [Bath-PUVA therapy of granuloma annulare. Hautarzt 1999; 50: 275-279.
6. Cyr PR. Diagnosis and management of granuloma annulare. Am Fam Physician 2006; 74: 1729-1734.
7. Breuer K, Gutzmer R, Volker B, Kapp A, Werfel T. Therapy of noninfectious granulomatous skin diseases with fumaric acid esters. Br J Dermatol 2005; 152: 1290-1295.
8. Eberlein-Konig B, Mempel M, Stahlecker J, Forer I, Ring J, Abeck D. Disseminated granuloma annulare-treatment with fumaric acid esters. Dermatology 2005; 210: 223-226.
9. Kreuter A, Gambichler T, Altmeyer P, Brockmeyer NH. Treatment of disseminated granuloma annulare with fumaric acid esters. BMC Dermatol 2002; 2: 5.
10. Hoefnagel JJ, Thio HB, Willemze R, Bouwes Bavinck JN. Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis. Br J Dermatol 2003; 149: 363-369.
11. Lehmann JC, Listopad JJ, Rentzsch CU, Igney FH, von Bonin A, Hennekes HH, et al. Dimethylfumarate induces immunosuppression via glutathione depletion and subsequent induction of heme oxygenase 1. J Invest Dermatol 2007; 127: 835-845.
12. Litjens NH, Rademaker M, Ravensbergen B, Rea D, van der Plas MJ, Thio B, et al. Monomethylfumarate affects polarization of monocyte-derived dendritic cells resulting in down-regulated Th1 lymphocyte responses. Eur J Immunol 2004; 34: 565-575.
13. de Jong R, Bezemer AC, Zomerdijk TP, van de Pouw-Kraan T, Ottenhoff TH, Nibbering PH. Selective stimulation of T helper 2 cytokine responses by the anti-psoriasis agent monomethylfumarate. Eur J Immunol 1996; 26: 2067-2074.
14. Ghoreschi K, Mrowietz U, Röcken M. A molecule solves psoriasis? Systemic therapies for psoriasis inducing interleukin 4 and Th2 responses. J Mol Med 2003; 81: 471-480.
15. Yazdi MR, Mrowietz U. Fumaric acid esters. Clin Dermatol 2008; 26: 522-526.
16. Ghoreschi K, Thomas P, Breit S, Dugas M, Mailhammer R, van Eden W, et al. Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease. Nat Med 2003; 9: 40-46.
17. Rubant SA, Ludwig RJ, Diehl S, Hardt K, Kaufmann R, Pfeilschifter JM, et al. Dimethylfumarate reduces leukocyte rolling in vivo through modulation of adhesion molecule expression. J Invest Dermatol 2008; 128: 326-331.